BRYAN BALL
CIK 1766522 · See remarks · last filed 2026-05-18
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.01M
Companies
4
Total Filings
20
Lifetime Open-Market Net
-$502.5K
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| WHWK | See remarks | 448,126 | $4.47 | $2.01M | -$635.1K | 6 | 2026-05-18 |
| Whitehawk Therapeutics, Inc. (AADI) Delisted | See remarks | 202,853 | $2.05 | $415.8K | -$5.0K | 1 | 2025-03-04 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Chief Qual. Officer & SVP Ops. | 25,178 | $19.00 | $478.4K | $0 | 5 | 2022-07-13 |
| IMMUNOMEDICS INC (IMMU) Delisted | Chief Quality Officer | 0 | — | — | $137.6K | 6 | 2020-10-23 |
Recent Filings · Page 2 of 2
20 filingsInsider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2022-04-13 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −531 | -$9.1K | EDGAR |
| 2022-01-31 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +3,600 | $0 | EDGAR |
| 2022-01-13 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Tax (F) | −2,455 | -$41.3K | EDGAR |
| 2021-01-11 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +25,000 | $0 | EDGAR |
| 2020-10-23 | IMMUNOMEDICS INC (IMMU) Delisted | Disp (D) | −10,000 | $0 | EDGAR |
| 2020-03-05 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-10-03 | IMMUNOMEDICS INC (IMMU) Delisted | Buy (P) | +5,000 | $70.9K | EDGAR |
| 2019-09-10 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | — | $0 | EDGAR |
| 2019-06-21 | IMMUNOMEDICS INC (IMMU) Delisted | Buy (P) | +5,000 | $66.8K | EDGAR |
| 2019-03-07 | IMMUNOMEDICS INC (IMMU) Delisted | Grant (A) | — | $0 | EDGAR |
Showing 11–20 of 20
Prev
Page 2 of 2
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.